HYLENEX recombinant (hyaluronidase) Injection is a sterile, recombinant human hyaluronidase solution intended for multiple uses, including increasing the dispersion and absorption of injected drugs, enhancing subcutaneous fluid administration, and improving the resorption of radiopaque agents in urography.
Key Benefits:
- Enhanced Fluid Administration: Facilitates absorption of subcutaneous fluids, aiding in hydration and drug dispersion.
- Increased Drug Absorption: Enhances the absorption of co-administered drugs, optimizing therapeutic effects.
- Versatile Clinical Use: Suitable for a range of injection routes, including intramuscular, subcutaneous, and peribulbar.
Dosage and Administration:
For Multiple Administration Routes:
- Subcutaneous Fluid Administration: Inject 150 USP units prior to subcutaneous fluid administration to aid absorption.
- Drug Absorption and Dispersion: Typically, 50-300 units, with 150 USP units most commonly used, added to the injection solution.
- Subcutaneous Urography: Inject 75 USP units subcutaneously over each scapula, followed by contrast medium injection.
Why Choose HYLENEX recombinant Injection?
- Efficient Fluid and Drug Absorption: Trusted to enhance the effectiveness of subcutaneous fluids and other injected drugs.
- Single-Dose Vial: Available as a 1 mL single-dose vial with 150 USP units/mL for precise dosing.
- Reliable for Diverse Procedures: Indicated for fluid administration, drug dispersion, and urography, supporting multiple therapeutic applications.
Warnings:
- Localized Infection Spread: Avoid injection into inflamed or infected areas to prevent spreading infections.
- Not for Intravenous Use: Effects on drug dispersion and absorption are not produced when administered intravenously.
- Ocular Precautions: Avoid direct ocular application to prevent eye damage.
Disclaimer:
This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
